Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCNC | P24863 | 11/20 | 0.74 |
| ▸ | CDK8 | P49336 | 11/20 | 0.74 |
| ▸ | ICAM1 | P05362 | 13/20 | 0.73 |
| ▸ | SELE | P16581 | 13/20 | 0.73 |
| ▸ | VCAM1 | P19320 | 7/20 | 0.73 |
| ▸ | CCNT1 | O60563 | 1/20 | 0.62 |
| ▸ | CDK9 | P50750 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7057083 | 0.93 | CCNC (0.74) | CCNCCDK8ICAM1SELEVCAM1 | |
| SCHEMBL7057734 | 0.93 | CCNC (0.74) | CCNCCDK8ICAM1SELEVCAM1 | |
| SCHEMBL7791104 | 0.93 | CCNC (0.74) | CCNCCDK8ICAM1SELEVCAM1 | |
| SCHEMBL7244832 | 0.93 | CCNC (0.74) | CCNCCDK8ICAM1SELEVCAM1 | |
| SCHEMBL7051786 | 0.91 | CCNC (0.71) | CCNCCDK8ICAM1SELEVCAM1 | |
| SCHEMBL7057677 | 0.88 | CCNC (0.81) | CCNCCDK8ICAM1SELEVCAM1 | |
| SCHEMBL7797454 | 0.88 | CCNC (0.81) | CCNCCDK8ICAM1SELEVCAM1 | |
| SCHEMBL7057662 | 0.88 | CCNC (0.81) | CCNCCDK8ICAM1SELEVCAM1 | |
| SCHEMBL7051780 | 0.85 | CCNC (0.77) | CCNCCDK8ICAM1SELEVCAM1 | |
| SCHEMBL7055341 | 0.85 | ICAM1 (1.00) | CCNCCDK8ICAM1SELEVCAM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030220365-A1 | Cell adhesion-inhibiting antiinflammatory compounds | STEWART ANDREW O (US) | 2003-11-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030220365-A1 | Cell adhesion-inhibiting antiinflammatory compounds | ICAM1, VCAM1, EPCAM | CCNC 1780/4885CDK8 2986/4885ICAM1 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.